Navigation Links
Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
Date:11/12/2007

- Data presented at American College of Rheumatology Annual Congress -

BOSTON, Nov. 12 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of three post-hoc analyses from two Phase III pivotal trials that showed ORENCIA(R) (abatacept) improved daily activity participation, such as work or household chores, physical and social-role independence and sleep quality in adult rheumatoid arthritis (RA) patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs), such as methotrexate (MTX) or tumor necrosis factor (TNF) antagonists.

These data are from post-hoc analyses of two Phase III pivotal trials investigating ORENCIA: AIM (Abatacept in Inadequate responders to Methotrexate) and ATTAIN (Abatacept Trial in Treatment of Anti-TNF Inadequate Responders).

"The chronic nature of RA can have a significant impact on a person's health-related quality of life, including independence, ability to perform daily activities and sleep quality," said George Wells, M.Sc., Ph.D., Professor of the Department of Epidemiology and Community Medicine, University of Ottawa.

About the Data

Poster presentations of these analyses of the AIM (n=433 for ORENCIA plus MTX; n=219 for placebo plus MTX) and ATTAIN (n=258 for ORENCIA plus DMARDs; n=133 for placebo plus DMARDs) studies evaluating health-related quality of life improvement in daily activity participation, independence and sleep quality in RA patients treated with ORENCIA(R) (abatacept) were presented last week at the ACR Annual Scientific Meeting in Boston, MA.

An analysis of the AIM and ATTAIN studies presented by Li, et al, looked at RA patients' ability to particip
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
2. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
5. ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
11. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Mallinckrodt plc (NYSE: MNK ) announced ... share repurchase program. The open-ended authorization permits the company ... ordinary shares. "Funding additional initiatives and ... we continue to pursue a range of focused growth ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... Furthering its commitment to provide patients ... B. Braun Medical Inc. (B. Braun) today announced ... Amerinet Inc., a leading national healthcare group purchasing organization. ... ) , Effective November 1, the new five-year agreement ...
... NEW YORK, Oct. 20 Code Blue, billed as ... the body combat dehydration, replenish vital nutrients, remove harmful ... L-Alanyl-L-Glutamine from Kyowa Hakko USA in the formulation. , ... all natural powerful ingredients in Code Blue allow you ...
Cached Medicine Technology:B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings 2B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings 3Code Blue Recovery Drink Features Sustamine(TM) from Kyowa Hakko 2
(Date:1/22/2015)... 2015 Liberty University has received accreditation for ... from the Council for Accreditation of Counseling & Related ... Center for Counseling & Family Studies , is under ... university’s new School of Behavioral Sciences. Prior to the formation ...
(Date:1/22/2015)... January 22, 2015 Woodloch Pines, an ... been selected by TripAdvisor as the number one best large ... best in the world for their annual Travelers’ Choice Awards. ... community . The website is home to millions of unbiased ...
(Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... Orlando, Florida (PRWEB) January 22, 2015 ... up today at the 2015 PGA Merchandise Show to ... lady and incredible female amateur golfer, Arlene McKitrick. The ... career female amateur golf tournament win. She won her ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... With millions of children,returning to classrooms around the country ... Smith is recommending that seniors,"return to school" also by ... "Many studies have demonstrated that by actively engaging your ... mentally and be more likely to,also maintain physical vigor," ...
... PAEF is a rare but often life-threatening cause of ... nearly 100% in the absence of surgical intervention, and ... This report presents one such case wherein the cause ... after discharge of the patient from the hospital. Few ...
... are coming!,Look for them in their yellow vests on the ... for Lions Candy Day, all over,Illinois," according to Foundation Executive ... forever in Illinois in 1952 thanks to,the dream of one ... small plastic white cane pins in return for donations. Over ...
... health experts to urge annual flu vaccine for nearly 85 percent of ... Americans, - Some influenza vaccine is already available in the U.S. Enough ... ... ...
... Sept. 23, 2008 -- Cancer death rates in the United ... shows that in Missouri the disparity in cancer incidence and ... result, cancer incidence (the rate of newly diagnosed cases) between ... remain higher for African Americans for some time. , ...
... conference of the Swiss Institute of,Bioinformatics in Berne, Switzerland, ... "Swiss success story". He said that he was,proud that ... the SIB,s 25 working,groups was today able to announce ... Amos Bairoch, head of the SIB,s Swiss-Prot group said: ...
Cached Medicine News:Health News:Medical Director of Renowned Facility Says Back to School Time is Also a Time for America's Seniors to Keep Learning 2Health News:What is the clinical features of primary aortoenteric fistula? 2Health News:Lions Taking to the Street Corners! 2Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 2Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 3Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 4Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 5Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 6Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 7Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 8Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 9Health News:Racial disparities decline for cancer in Missouri 2Health News:Racial disparities decline for cancer in Missouri 3Health News:Swiss Institute of Bioinformatics announces major breakthrough 2Health News:Swiss Institute of Bioinformatics announces major breakthrough 3
Cemented foundation 450 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
The link ribbed hip stem for cementless primary hip replacement surgery....
The cemented hip joint prosthesis system....
Medicine Products: